So what you’re trying to say is when two companies have the same/similar intrinsic value, you buy the one with the lowest share price. Should’ve just said that.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential